# Maze Therapeutics, Inc. (MAZE)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MAZE/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 20.00M | $ -24.21M | $ -39.21M | $ 22.39M | $ 341.70M |
| 2025 | $ 0 | $ -134.26M | $ -115.43M | $ 23.31M | $ 354.97M |
| 2024 | $ 176.06M | $ 54.90M | $ 78.63M | $ 26.63M | $ 196.90M |
| 2023 | $ 0 | $ -55.49M | $ -43.95M | $ 49.62M | $ 10.05M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.07 |
| Liabilities / Eq | 0.23 |
| Current Ratio | 17.88 |

## Other views

- [Metrics](https://sponda.capital/en/MAZE.md)
- [Charts](https://sponda.capital/en/MAZE/charts.md)
- [Compare](https://sponda.capital/en/MAZE/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.